Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-05-08

Clinical Trial Update: Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD [Phase 1, Phase 2]

View source ↗

Summary

A University of British Columbia trial is evaluating the effects of low-dose versus normal-dose psychostimulants on executive function in individuals with atten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Attention Deficit Hyperactivity Disorders | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING